Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 9/20 | 0.34 |
| ▸ | FEN1 | P39748 | 9/20 | 0.34 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.31 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20007062 | 0.85 | HSD17B1 (0.38) | FEN1HSD17B1HSD17B2 | |
| SCHEMBL21397861 | 0.83 | — | — | |
| SCHEMBL21398041 | 0.83 | HPGDS (0.36) | ALOX5APFEN1HSD17B1HSD17B2 | |
| SCHEMBL19933579 | 0.82 | FEN1 (0.43) | ALOX5APFEN1HSD17B1HSD17B2 | |
| SCHEMBL19933615 | 0.80 | ALOX5AP (0.40) | ALOX5APFEN1HSD17B1HSD17B2 | |
| SCHEMBL19794445 | 0.80 | LDHA (0.43) | ALOX5APFEN1HSD17B1HSD17B2 | |
| SCHEMBL19794461 | 0.78 | ALOX5AP (0.40) | ALOX5APFEN1HSD17B1HSD17B2 | |
| SCHEMBL21721916 | 0.77 | ALOX5AP (0.39) | ALOX5APFEN1HSD17B1HSD17B2 | |
| SCHEMBL20007064 | 0.75 | KDR (0.35) | HSD17B1HSD17B2 | |
| SCHEMBL21125647 | 0.72 | TRPV1 (0.40) | ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| US-20190292210-A1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-09-26 | — | — | US | disclosed |
| WO-2018054798-A1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2018-03-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292210-A1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | AP2M1, MCU, AP3M1 | ALOX5AP 3921/4885FEN1 1734/4885HSD17B1 4437/4885 |
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | AP2M1, MCU, AP3M1 | ALOX5AP 3921/4885FEN1 1734/4885HSD17B1 4437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.